Cisplatin and its analogues in the treatment of advanced breast cancer: a review
about
Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agentsCisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase II study.A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanesWeekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study.Taxol in the management of cancers of the breast and the ovary.Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary cultureEnhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cellsStructure and function of "metalloantibiotics".Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.Visualizing inhibition of nucleosome mobility and transcription by cisplatin-DNA interstrand crosslinks in live mammalian cellsRenal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in RatsPharmacogenetics of chemotherapy efficacy in breast cancer.Optical molecular imaging approach for rapid assessment of response of individual cancer cells to chemotherapy.The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.Platinum-based chemotherapy in triple-negative breast cancer.Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
P2860
Q28534123-DC128912-9AC6-4A56-95FA-D96929814417Q33330720-BB0F5710-6AA1-4E56-96DD-0C13E50FAAEBQ33334489-9447470A-3994-4DA0-8801-E3848CF24AA0Q33426722-3C66E0E8-0F40-4D3D-BCE0-ABFBD1C9ACE7Q33503243-A0F6BF37-A6F6-4FD1-96A6-162C9B78C95DQ33885729-4FD3BA9F-F356-4752-A00B-B29D84B7DC70Q34619471-A64FF2E3-49CE-4BCA-A05B-D7B6E432F7AEQ34647893-74D98938-FDBC-49BD-AE0F-58B51BFE679BQ35206410-644F7322-D9B4-4FDC-866B-BD56D6E0929DQ35701943-4E37C5CE-55CA-4C16-8755-56DB4B2B0D46Q36616994-7BE11D3D-51E3-4A80-A212-7DB36C1B76BFQ37026980-72EF58DD-0C09-4ED2-A60A-A94ABD72D2B5Q37704672-7B3613AE-E670-4816-8FB8-3ABCE98A5F0FQ38003703-CD0B4B18-B76F-4AC2-87D2-30CB0178DE86Q42053570-6106AF43-F17C-4A9A-932A-934B02A24BAAQ42442346-F36D8B55-96E1-4571-8145-E05FCC2E1E8BQ46358330-716C52B5-AE93-4033-B7D3-52F811E04514Q54672469-D15AB5F5-2BA8-43BE-8BE0-65D1F4B3DFAC
P2860
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@ast
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@en
type
label
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@ast
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@en
prefLabel
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@ast
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@en
P2860
P921
P356
P1476
Cisplatin and its analogues in the treatment of advanced breast cancer: a review
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1992.169
P407
P577
1992-06-01T00:00:00Z